New drug TML-6 tested for safety in healthy adults
Knowledge-focused
Completed
This completed Phase 1 trial tested the safety and tolerability of TML-6, an oral drug, in 72 healthy volunteers aged 18 to 80. Researchers gave single or multiple doses to see how the body processes the drug and whether food affects absorption. Since this study only involved hea…
Phase: PHASE1 • Sponsor: Merry Life Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC